Based on recent data, Calliditas Therapeutics AB (publ) (CALT) shows an Average True Range (ATR) of 1.05 and an Enterprise Value of 5.39B. Its average trading volume over the past 3 months is N/A, indicating liquidity. These fundamental metrics provide insight into CALT's underlying financial health and market activity.
| ATR | 1.05 |
| Enterprise Value | 5.39B |
| Avg Vol (3 Months) | - |
| Avg Vol (10 Days) | - |
Calliditas Therapeutics AB (publ) (CALT) technical indicators as of May 15, 2026: the SMA 20 is -0.76%, SMA 50 at 1.28%, and SMA 200 at 39.49%. The RSI 14 value is 50.49, suggesting its current momentum. These technical analysis signals help assess CALT's price trends and potential future movements.
| SMA 20 | -0.76% |
| SMA 50 | 1.28% |
| SMA 200 | 39.49% |
| RSI 14 | 50.49 |
Calliditas Therapeutics AB (publ) (CALT) stock performance overview as of May 15, 2026: The 52-week high is N/A (currently -6.98% below), and the 52-week low is N/A (currently 162.3% above). Over the past year, CALT's performance is 146.91%, compared to the S&P 500's 12.09% change.
| 52-Week High | N/A |
| 52-Week High Chg | -6.98% |
| 52-Week Low | N/A |
| 52-Week Low Chg | +162.30% |
| S&P 500 52-Week Chg | 12.09% |
According to market data, Calliditas Therapeutics AB (publ) (CALT) stock's recent performance metrics show that over the last month, CALT is -1.33%, with a Year-to-Date (YTD) performance of 55.38%. Over the past year, the stock has seen a 146.91% change. These figures summarize CALT's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | N/A | N/A | N/A | N/A | N/A | N/A |
| Low | N/A | N/A | N/A | N/A | N/A | N/A |
| Performance | 0 | -1.33% | +3.28% | +87.79% | +146.91% | +55.38% |
According to current financial data, CALT stock's P/E (TTM) ratio is -21.52, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.22. Key valuation ratios for CALT, including P/S (16.63), P/B (29.97), and P/FCF (-44.86), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | CALT | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | -21.52 | -1.22 | -5.12 | 32.59 |
| P/S (TTM) | 16.63 | 3.69 | 464.32 | 5.98 |
| P/B (TTM) | 29.97 | 5.18 | 13.84 | 4.67 |
| P/FCF (TTM) | -44.86 | 1009.4 | -429.1 | 32.44 |
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep